{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:25:46Z","timestamp":1787739946853,"version":"build-2784847793"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A major question in clinical science is how to study the natural course of a chronic disease from inception to end, which is challenging because it is impractical to follow patients over decades. Here, we developed BETR (Bayesian entry time realignment), a hierarchical Bayesian method for investigating the long-term natural history of diseases using data from patients followed over short durations. A simulation study shows that BETR outperforms an existing method that ignores patient-level variation in progression rates. BETR, when combined with a common Bayesian model comparison tool, can identify the correct disease progression function nearly 100% of the time, with high accuracy in estimating the individual disease durations and progression rates. Application of BETR in patients with geographic atrophy, a disease with a known natural history model, shows that it can identify the correct disease progression model. Applying BETR in patients with Huntington\u2019s disease demonstrates that the progression of motor symptoms follows a second order function over approximately 20\u00a0years.<\/jats:p>","DOI":"10.1038\/s41598-022-08919-1","type":"journal-article","created":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T11:03:15Z","timestamp":1647946995000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A hierarchical Bayesian entry time realignment method to study the long-term natural history of diseases"],"prefix":"10.1038","volume":"12","author":[{"given":"Liangbo L.","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucian V.","family":"Del Priore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua L.","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,22]]},"reference":[{"key":"8919_CR1","doi-asserted-by":"crossref","unstructured":"Paz MP, et al. Rare diseases epidemiology research. In Rare Diseases Epidemiology 17\u201339 (2010).","DOI":"10.1007\/978-90-481-9485-8_2"},{"key":"8919_CR2","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/cpt.423","volume":"100","author":"NP Jewell","year":"2016","unstructured":"Jewell, N. P. Natural history of diseases: Statistical designs and issues. Clin. Pharmacol. Ther. 100, 353\u2013361 (2016).","journal-title":"Clin. Pharmacol. Ther."},{"key":"8919_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s40495-016-0066-x","volume":"2","author":"SF Cook","year":"2016","unstructured":"Cook, S. F. & Bies, R. R. Disease progression modeling: Key concepts and recent developments. Curr. Pharmacol. Rep. 2, 221\u2013230 (2016).","journal-title":"Curr. Pharmacol. Rep."},{"key":"8919_CR4","doi-asserted-by":"crossref","unstructured":"The natural history of disease. N. Engl. J. Med. 240, 442\u2013443. https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJM194903172401111 (1949).","DOI":"10.1056\/NEJM194903172401111"},{"key":"8919_CR5","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.oret.2020.03.020","volume":"4","author":"LL Shen","year":"2020","unstructured":"Shen, L. L., Sun, M., Grossetta Nardini, H. K. & Del Priore, L. V. Progression of unifocal vs. multifocal geographic atrophy in age-related macular degeneration: A systematic review and meta-analysis. Ophthalmol. Retina 4, 899\u2013910 (2020).","journal-title":"Ophthalmol. Retina"},{"key":"8919_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ajo.2006.09.043","volume":"143","author":"AR Shah","year":"2007","unstructured":"Shah, A. R. & Del Priore, L. V. Progressive visual loss in subfoveal exudation in age-related macular degeneration: A meta-analysis using lineweaver-burke plots. Am. J. Ophthalmol. 143, 83\u201389 (2007).","journal-title":"Am. J. Ophthalmol."},{"key":"8919_CR7","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1016\/j.ophtha.2009.03.055","volume":"116","author":"AR Shah","year":"2009","unstructured":"Shah, A. R. & Del Priore, L. V. Natural history of predominantly classic, minimally classic, and occult subgroups in exudative age-related macular degeneration. Ophthalmology 116, 1901\u20131907 (2009).","journal-title":"Ophthalmology"},{"key":"8919_CR8","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1136\/bjo.2008.149674","volume":"93","author":"AR Shah","year":"2009","unstructured":"Shah, A. R. & Del Priore, L. V. Duration of action of intravitreal ranibizumab and bevacizumab in exudative amd eyes based on macular volume measurements. Br. J. Ophthalmol. 93, 1027\u20131032 (2009).","journal-title":"Br. J. Ophthalmol."},{"key":"8919_CR9","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1001\/jamaophthalmol.2013.818","volume":"131","author":"TYA Liu","year":"2013","unstructured":"Liu, T. Y. A., Shah, A. R. & Del Priore, L. V. Progression of lesion size in untreated eyes with exudative age-related macular degeneration: A meta-analysis using lineweaver-burk plots. JAMA Ophthalmol. 131, 335\u2013340 (2013).","journal-title":"JAMA Ophthalmol."},{"key":"8919_CR10","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.oret.2018.01.019","volume":"2","author":"L Shen","year":"2018","unstructured":"Shen, L., Liu, F., Grossetta Nardini, H. & Del Priore, L. V. Natural history of geographic atrophy in untreated eyes with nonexudative age-related macular degeneration: A systematic review and meta-analysis. Ophthalmol. Retina 2, 914\u2013921 (2018).","journal-title":"Ophthalmol. Retina"},{"key":"8919_CR11","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.oret.2018.11.013","volume":"3","author":"LL Shen","year":"2019","unstructured":"Shen, L. L., Liu, F., Grossetta Nardini, H. K. & Del Priore, L. V. Fellow eye status is a biomarker for the progression rate of geographic atrophy: A systematic review and meta-analysis. Ophthalmol. Retina 3, 305\u2013315 (2019).","journal-title":"Ophthalmol. Retina"},{"key":"8919_CR12","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1097\/IAE.0000000000002480","volume":"39","author":"LL Shen","year":"2019","unstructured":"Shen, L. L., Liu, F., Nardini, H. G. & Del Priore, L. V. Reclassification of fundus autofluorescence patterns surrounding geographic atrophy based on progression rate: A systematic review and meta-analysis. Retina 39, 1829\u20131839 (2019).","journal-title":"Retina"},{"key":"8919_CR13","first-page":"2","volume":"61","author":"LL Shen","year":"2020","unstructured":"Shen, L. L., Sun, M., Khetpal, S., Grossetta Nardini, H. K. & Del Priore, L. V. Topographic variation of the growth rate of geographic atrophy in nonexudative age-related macular degeneration: A systematic review and meta-analysis. Investig. Ophthalmol. Vis. Sci. 61, 2 (2020).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"8919_CR14","unstructured":"Shen, L. L. et al. Natural history of central sparing in geographic atrophy secondary to non-exudative age-related macular degeneration. Br. J. Ophthalmol. pp. 1\u20137 (2020)."},{"key":"8919_CR15","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.ophtha.2019.05.015","volume":"126","author":"LL Shen","year":"2019","unstructured":"Shen, L. L., Sun, M., Grossetta Nardini, H. K. & Del Priore, L. V. Natural history of autosomal recessive stargardt disease in untreated eyes: A systematic review and meta-analysis of study- and individual-level data. Ophthalmology 126, 1288\u20131296 (2019).","journal-title":"Ophthalmology"},{"key":"8919_CR16","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.oret.2020.03.003","volume":"4","author":"LL Shen","year":"2020","unstructured":"Shen, L. L. et al. Long-term natural history of atrophy in eyes with choroideremia\u2014A systematic review and meta-analysis of individual-level data. Ophthalmol. Retina 4, 840\u2013852 (2020).","journal-title":"Ophthalmol. Retina"},{"key":"8919_CR17","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1136\/bjophthalmol-2020-316028","volume":"105","author":"LL Shen","year":"2021","unstructured":"Shen, L. L. et al. Long-term natural history of visual acuity in eyes with choroideremia: A systematic review and meta-analysis of data from 1004 individual eyes. Br. J. Ophthalmol. 105, 271\u2013278 (2021).","journal-title":"Br. J. Ophthalmol."},{"key":"8919_CR18","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3233\/JAD-2011-110551","volume":"26","author":"E Yang","year":"2011","unstructured":"Yang, E. et al. Quantifying the pathophysiological timeline of Alzheimer\u2019s disease. J. Alzheimers Dis. 26, 745\u2013753 (2011).","journal-title":"J. Alzheimers Dis."},{"key":"8919_CR19","first-page":"97","volume":"17","author":"WD Vogl","year":"2014","unstructured":"Vogl, W. D., Prosch, H., Muller-Mang, C., Schmidt-Erfurth, U. & Langs, G. Longitudinal alignment of disease progression in fibrosing interstitial lung disease. Med. Image Comput. Comput. Assist. Interv. 17, 97\u2013104 (2014).","journal-title":"Med. Image Comput. Comput. Assist. Interv."},{"key":"8919_CR20","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1136\/bjophthalmol-2016-308422","volume":"101","author":"FG Schlanitz","year":"2017","unstructured":"Schlanitz, F. G. et al. Drusen volume development over time and its relevance to the course of age-related macular degeneration. Br. J. Ophthalmol. 101, 198\u2013203 (2017).","journal-title":"Br. J. Ophthalmol."},{"key":"8919_CR21","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.1091\/mbc.e13-01-0004","volume":"25","author":"J Berro","year":"2014","unstructured":"Berro, J. & Pollard, T. D. Local and global analysis of endocytic patch dynamics in fission yeast using a new \u201ctemporal superresolution\u201d realignment method. Mol. Biol. Cell 25, 3501\u20133514 (2014).","journal-title":"Mol. Biol. Cell"},{"key":"8919_CR22","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1109\/TPAMI.2005.85","volume":"27","author":"E Shechtman","year":"2005","unstructured":"Shechtman, E., Caspi, Y. & Irani, M. Space-time super-resolution. IEEE Trans. Pattern Anal. Mach. Intell. 27, 531\u2013545 (2005).","journal-title":"IEEE Trans. Pattern Anal. Mach. Intell."},{"key":"8919_CR23","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1136\/jnnp-2014-308153","volume":"86","author":"WL Kuan","year":"2015","unstructured":"Kuan, W. L. et al. Modelling the natural history of Huntington\u2019s disease progression. J. Neurol. Neurosurg Psychiatry 86, 1143\u20131149 (2015).","journal-title":"J. Neurol. Neurosurg Psychiatry"},{"key":"8919_CR24","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/1467-9868.00353","volume":"64","author":"DJ Spiegelhalter","year":"2002","unstructured":"Spiegelhalter, D. J., Best, N. G., Carlin, B. P. & Van Der Linde, A. Bayesian measures of model complexity and fit. J. R. Stat. Soc. Ser. B (Stat. Methodol.) 64, 583\u2013639 (2002).","journal-title":"J. R. Stat. Soc. Ser. B (Stat. Methodol.)"},{"key":"8919_CR25","doi-asserted-by":"publisher","first-page":"AMD1","DOI":"10.1167\/iovs.17-23315","volume":"59","author":"S Thiele","year":"2018","unstructured":"Thiele, S. et al. Multimodal imaging patterns for development of central atrophy secondary to age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 59, AMD1 (2018).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"8919_CR26","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1016\/j.ophtha.2018.03.059","volume":"125","author":"PJ Rosenfeld","year":"2018","unstructured":"Rosenfeld, P. J. et al. Emixustat hydrochloride for geographic atrophy secondary to age-related macular degeneration: A randomized clinical trial. Ophthalmology 125, 1556\u20131567 (2018).","journal-title":"Ophthalmology"},{"issue":"2","key":"8919_CR27","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000510507","volume":"64","author":"J Wang","year":"2021","unstructured":"Wang, J. & Ying, G.-S. Growth rate of geographic atrophy secondary to age-related macular degeneration: A meta-analysis of natural history studies and implications for designing future trials. Ophthalmic Res. 64(2), 205\u2013215 (2021).","journal-title":"Ophthalmic Res."},{"key":"8919_CR28","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.ophtha.2010.08.018","volume":"118","author":"Z Yehoshua","year":"2011","unstructured":"Yehoshua, Z. et al. Progression of geographic atrophy in age-related macular degeneration imaged with spectral domain optical coherence tomography. Ophthalmology 118, 679\u2013686 (2011).","journal-title":"Ophthalmology"},{"key":"8919_CR29","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.ophtha.2018.05.028","volume":"125","author":"TD Keenan","year":"2018","unstructured":"Keenan, T. D. et al. Progression of geographic atrophy in age-related macular degeneration: Areds2 report number 16. Ophthalmology 125, 1913\u20131928 (2018).","journal-title":"Ophthalmology"},{"key":"8919_CR30","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1001\/jamaophthalmol.2013.572","volume":"131","author":"WJ Feuer","year":"2013","unstructured":"Feuer, W. J. et al. Square root transformation of geographic atrophy area measurements to eliminate dependence of growth rates on baseline lesion measurements: A reanalysis of age-related eye disease study report no. 26. JAMA Ophthalmol. 131, 110\u2013111 (2013).","journal-title":"JAMA Ophthalmol."},{"key":"8919_CR31","doi-asserted-by":"publisher","DOI":"10.21034\/sr.148","volume-title":"Evaluating the Accuracy of Sampling-based Approaches to the Calculation of Posterior Moments","author":"JF Geweke","year":"1991","unstructured":"Geweke, J. F. Evaluating the Accuracy of Sampling-based Approaches to the Calculation of Posterior Moments (Federal Reserve Bank of Minneapolis, 1991)."},{"key":"8919_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-87458-6","volume-title":"Mixed Effects Models and Extensions in Ecology with R","author":"A Zuur","year":"2009","unstructured":"Zuur, A., Ieno, E. N., Walker, N., Saveliev, A. A. & Smith, G. M. Mixed Effects Models and Extensions in Ecology with R (Springer Science & Business Media, 2009)."},{"key":"8919_CR33","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ajo.2015.04.003","volume":"160","author":"AR Rudnicka","year":"2015","unstructured":"Rudnicka, A. R. et al. Incidence of late-stage age-related macular degeneration in American whites: Systematic review and meta-analysis. Am. J. Ophthalmol. 160, 85-93.e83 (2015).","journal-title":"Am. J. Ophthalmol."},{"key":"8919_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1001\/archophthalmol.2010.318","volume":"129","author":"R Klein","year":"2011","unstructured":"Klein, R. et al. Prevalence of age-related macular degeneration in the US population. Arch. Ophthalmol. 129, 75\u201380 (2011).","journal-title":"Arch. Ophthalmol."},{"key":"8919_CR35","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1602\/neurorx.1.2.255","volume":"1","author":"RH Myers","year":"2004","unstructured":"Myers, R. H. Huntington\u2019s disease genetics. NeuroRx 1, 255\u2013262 (2004).","journal-title":"NeuroRx"},{"key":"8919_CR36","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1399-0004.2004.00241.x","volume":"65","author":"DR Langbehn","year":"2004","unstructured":"Langbehn, D. R. et al. A new model for prediction of the age of onset and penetrance for Huntington\u2019s disease based on cag length. Clin. Genet. 65, 267\u2013277 (2004).","journal-title":"Clin. Genet."},{"key":"8919_CR37","doi-asserted-by":"publisher","first-page":"107804","DOI":"10.1016\/j.celrep.2020.107804","volume":"31","author":"AE Eastman","year":"2020","unstructured":"Eastman, A. E. et al. Resolving cell cycle speed in one snapshot with a live-cell fluorescent reporter. Cell Rep. 31, 107804 (2020).","journal-title":"Cell Rep."},{"key":"8919_CR38","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong, W. L. et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: A systematic review and meta-analysis. Lancet Glob. Health 2, e106\u2013e116 (2014).","journal-title":"Lancet Glob. Health"},{"key":"8919_CR39","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1001\/jamaophthalmol.2018.1544","volume":"136","author":"FG Holz","year":"2018","unstructured":"Holz, F. G. et al. Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and spectri phase 3 randomized clinical trials. JAMA Ophthalmol. 136, 666\u2013677 (2018).","journal-title":"JAMA Ophthalmol."},{"key":"8919_CR40","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ophtha.2019.07.011","volume":"127","author":"DS Liao","year":"2020","unstructured":"Liao, D. S. et al. Complement c3 inhibitor pegcetacoplan for geographic atrophy secondary to age-related macular degeneration: A randomized phase 2 trial. Ophthalmology 127, 186\u2013195 (2020).","journal-title":"Ophthalmology"},{"issue":"9","key":"8919_CR41","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.oret.2020.03.019","volume":"4","author":"BJ Kim","year":"2020","unstructured":"Kim, B. J. et al. Orally administered alpha lipoic acid as a treatment for geographic atrophy: A randomized clinical trial. Ophthalmol. Retina 4(9), 889\u2013898 (2020).","journal-title":"Ophthalmol. Retina"},{"issue":"4","key":"8919_CR42","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ophtha.2020.08.027","volume":"128","author":"GJ Jaffe","year":"2021","unstructured":"Jaffe, G. J. et al. C5 inhibitor avacincaptad pegol for geographic atrophy due to age-related macular degeneration: A randomized pivotal phase 2\/3 trial. Ophthalmology 128(4), 576\u2013586 (2021).","journal-title":"Ophthalmology"},{"issue":"9","key":"8919_CR43","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.oret.2020.12.002","volume":"5","author":"LL Shen","year":"2021","unstructured":"Shen, L. L. et al. Geographic atrophy growth is strongly related to lesion perimeter: Unifying effects of lesion area, number, and circularity on growth. Ophthalmol. Retina 5(9), 868\u2013878 (2021).","journal-title":"Ophthalmol. Retina"},{"key":"8919_CR44","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1016\/j.ophtha.2013.03.029","volume":"120","author":"N Joachim","year":"2013","unstructured":"Joachim, N. et al. Incidence and progression of geographic atrophy: Observations from a population-based cohort. Ophthalmology 120, 2042\u20132050 (2013).","journal-title":"Ophthalmology"},{"issue":"8","key":"8919_CR45","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.oret.2020.11.003","volume":"5","author":"LL Shen","year":"2021","unstructured":"Shen, L. L. et al. Relationship of topographic distribution of geographic atrophy to visual acuity in nonexudative age-related macular degeneration. Ophthalmol. Retina 5(8), 761\u2013774 (2021).","journal-title":"Ophthalmol. Retina"},{"key":"8919_CR46","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0197-2456(99)00031-8","volume":"20","author":"Age-Related Eye Disease Study Research Group","year":"1999","unstructured":"Age-Related Eye Disease Study Research Group. The age-related eye disease study (AREDS): Design implications AREDS report no. 1. Control Clin. Trials 20, 573\u2013600 (1999).","journal-title":"Control Clin. Trials"},{"key":"8919_CR47","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1001\/archopht.119.10.1417","volume":"119","author":"Age-Related Eye Disease Study Research Group","year":"2001","unstructured":"Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins c and e, beta carotene, and zinc for age-related macular degeneration and vision loss: Areds report no. 8. Arch. Ophthalmol. 119, 1417\u20131436 (2001).","journal-title":"Arch. Ophthalmol."},{"key":"8919_CR48","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/ng1007-1181","volume":"39","author":"MD Mailman","year":"2007","unstructured":"Mailman, M. D. et al. The ncbi dbgap database of genotypes and phenotypes. Nat. Genet. 39, 1181\u20131186 (2007).","journal-title":"Nat. Genet."},{"key":"8919_CR49","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1186\/s12859-017-1934-z","volume":"18","author":"CT Rueden","year":"2017","unstructured":"Rueden, C. T. et al. Imagej 2: Imagej for the next generation of scientific image data. BMC Bioinform. 18, 529 (2017).","journal-title":"BMC Bioinform."},{"key":"8919_CR50","unstructured":"Plummer, M., Stukalov, A. & Denwood, M. Package \u2018rjags\u2019. (2019)."},{"key":"8919_CR51","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ophtha.2015.09.036","volume":"123","author":"S Schmitz-Valckenberg","year":"2016","unstructured":"Schmitz-Valckenberg, S. et al. Natural history of geographic atrophy progression secondary to age-related macular degeneration (geographic atrophy progression study). Ophthalmology 123, 361\u2013368 (2016).","journal-title":"Ophthalmology"},{"key":"8919_CR52","doi-asserted-by":"publisher","first-page":"7640","DOI":"10.1167\/iovs.11-7457","volume":"52","author":"S Schmitz-Valckenberg","year":"2011","unstructured":"Schmitz-Valckenberg, S. et al. Semiautomated image processing method for identification and quantification of geographic atrophy in age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 52, 7640\u20137646 (2011).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"8919_CR53","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1097\/IAE.0000000000001283","volume":"36","author":"SR Sadda","year":"2016","unstructured":"Sadda, S. R. et al. Clinical endpoints for the study of geographic atrophy secondary to age-related macular degeneration. Retina 36, 1806\u20131822 (2016).","journal-title":"Retina"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08919-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08919-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08919-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:52:14Z","timestamp":1669337534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08919-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,22]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["8919"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-08919-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,22]]},"assertion":[{"value":"24 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.L.S.: Consultant\u2014Boehringer Ingelheim; L.V.D.P.: Consultant\u2014Boehringer Ingelheim. J.L.W.: None.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4869"}}